Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1992
10/28/1992EP0510271A1 Novel R106 compounds
10/28/1992EP0510270A1 Viscoelastic solution
10/28/1992EP0510186A1 Therapeutic uses of melanin
10/28/1992EP0510082A1 Oxidized variants of gm-csf
10/28/1992EP0510079A1 Proteins produced by human lymphocytes, dna sequence coding these proteins, and pharmaceutical and biological uses thereof
10/28/1992EP0510063A1 Anti-inflammatory peptides and treatment to inhibit vascular leakage in injured tissues
10/28/1992EP0510052A1 Medicament for treatment of heart failure
10/28/1992EP0509989A1 Method of preparing ribonuclease dimers.
10/28/1992EP0509984A1 Method of preparing lysozyme dimers
10/28/1992EP0504291A4 Novel proteins with oncostatin m activity and process for their preparation
10/28/1992EP0441832A4 Composition and treatment with biologically active peptides and certain anions
10/28/1992EP0235205B1 Peptide analogues of mammalian insulin-like growth factor-1
10/28/1992EP0181342B1 Method of treating hypertension in vertebrates
10/28/1992CN1065682A Trans-splicing ribozymes
10/28/1992CN1065681A Cell ablation using trans-splicing ribozymes
10/28/1992CN1018793B Homologues of aprotinin produced from recombinant host, process, expression vector and recombinant host therefor and pharmaceutical use thereof
10/28/1992CA2067039A1 Neurotrophic peptide derivatives
10/27/1992US5159066 Recombination activating gene (RAG-1)
10/27/1992US5159064 Subjecting solution to pH of about 4 a temperature of at least 5 degrees delsius for at least 16 hours
10/27/1992US5159061 Hypotensive agent, diuretic
10/27/1992US5159060 Cytotoxic boronic acid peptide analogs
10/27/1992US5158959 Decahydroisoquinoline carboxylic acids
10/27/1992US5158936 Treating or prevention of tissue damage, inflammation, bone resporpption and muscular dystrophy
10/27/1992US5158935 Human epidermal growth factor having substitution at position 11
10/27/1992US5158934 Method of inducing bone growth using TGF-β
10/27/1992US5158886 Monoclonal antibodies specific for free N-acetylfuraminic acid and beta-glycosides and beta-glycoconjugates thereof
10/27/1992US5158885 Mouse monoclonal antibodies raised to the t-cell line hsb-2 and t-cell chronic lymphocytic leukemia (t-cll) cells react with normal human t and b lymphocytes and monocytes
10/27/1992US5158884 Polypeptides
10/27/1992US5158876 Process for the production of antibiotic R106 by a strain of Aureobasidium pullulans
10/27/1992US5158875 Production of biologically active insulin-like growth factor i from high expression host cell systems
10/27/1992US5158777 Captopril formulation providing increased duration of activity
10/27/1992US5157894 Orientation and loading device for vials in general and syringe vials in particular
10/27/1992CA2067304A1 Superactive grf analogs
10/27/1992CA2067014A1 Use of anti-mullerian hormone alone or in combination with aromatase inhibitors for reversal of female sexual phenotype in poultry
10/27/1992CA2066931A1 Bfgf mutein and its production
10/27/1992CA1309558C D-gl conjugate therapy
10/27/1992CA1309557C Leukotriene antagonists
10/27/1992CA1309347C Delayed/sustained release of macromolecules
10/27/1992CA1309346C Pharmaceutical administration systems containing chemotactic peptides
10/27/1992CA1309340C Cationized antibodies for delivery through the blood-brain barrier
10/25/1992WO1992019254A1 α-SUBSTITUTED POLYPEPTIDES HAVING THERAPEUTIC ACTIVITY
10/25/1992CA2106764A1 Ó-substituted polypeptides having therapeutic activity
10/24/1992CA2066810A1 Cytomodulating conjugates of members of specific binding pairs
10/23/1992WO1992018163A1 Medicine for intraocular operation
10/23/1992CA2085732A1 Pharmaceutical composition for use in intraocular surgery
10/21/1992EP0509833A1 An intracorporeally injectable composition for implanting highly concentrated cross-linked atelocollagen
10/21/1992EP0509831A1 Precursor form of bovine growth hormone releasing factor and related DNA compounds
10/21/1992EP0509769A2 Heterocyclic amides having HLE inhibiting activity
10/21/1992EP0509719A1 Compounds, vectors and methods for expressing human, cytosolic phospholipase A2
10/21/1992EP0509553A1 Anti-lymphotoxin antibody, its production and use
10/21/1992EP0509442A1 Use of neutral endopeptidase inhibitors in the treatment of nephrotoxicity
10/21/1992EP0509080A1 Inhibitors and substrates of thrombin
10/21/1992EP0509056A1 Target-specific, cytotoxic, recombinant pseudomonas exotoxin
10/21/1992EP0509054A1 Preparation of fibrinogen/factor xiii precipitate
10/21/1992EP0509041A1 Fibrin sealant delivery method
10/21/1992EP0509027A1 A process to correct and optimize the composition of a feed.
10/21/1992EP0508983A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
10/21/1992EP0481000A4 Receptors for fibroblast growth factors
10/21/1992EP0191827B1 Method of removing n-terminal amino acid residues from eucaryotic polypetide analogs and polypeptides produced thereby
10/21/1992CN1065490A Dna sequences which code for virulence characteristics of streptococcus suis and polypeptides and antibody derived therefrom
10/21/1992CN1065465A Polyethylene protein conjugates
10/20/1992WO1992018618A1 Modified plant viruses as vectors
10/20/1992WO1992018156A1 Bradykinin antagonist peptides
10/20/1992WO1992018155A1 Bradykinin type peptides
10/20/1992WO1992018154A1 Human bone derived insulin like growth factor binding protein
10/20/1992US5157115 Regulation of expression
10/20/1992US5157113 Removal of nucleic acids from monoclonal antibody preparations
10/20/1992US5157112 Antibodies immunoreactive with the T-cell growth factor, P40
10/20/1992US5157110 Synthetic, anti-complement protein
10/20/1992US5157106 N-terminal deletions of lymphotoxin, their preparation and use
10/20/1992US5157041 Viricides
10/20/1992US5157025 Method for lowering serum cholesterol employing a phosphorus containing ace inhibitor alone or in combination with a cholesterol lowering drug
10/20/1992US5157023 Antipyretic and anti-inflammatory lys pro val compositions and method of use
10/20/1992US5157022 Method for reducing blood cholesterol using arginine
10/20/1992US5157021 Antidiabetic agents, insensitive to tryptic activity
10/20/1992US5157020 Two covalently bonded peptides
10/20/1992US5157019 Serine protease inhibitors
10/20/1992US5157004 Viricide, antitumor agent
10/20/1992US5156969 Treating vascular disorders
10/20/1992US5156967 Treatment with ion exchange resin
10/20/1992US5156960 Microbial process for the production of immunosuppressive antibiotics
10/20/1992US5156957 Transformed mammalian cell containing an expression vector which is capable of producing a heterodimeric human fertility hormone coded by a distinct RNA
10/20/1992US5156949 Immunoassays for antibody to human immunodeficiency virus using recombinant antigens
10/20/1992US5156851 Coated veterinary implants
10/20/1992CA2107475A1 Human bone derived insulin like growth factor binding protein
10/20/1992CA2066335A1 Precursor form of bovine growth hormone releasing factor and related dna compounds
10/20/1992CA2065658A1 Conjugates of liposomes or microbeads and antibodies specific for t lymphocytes and their use in vivo immune modulators
10/20/1992CA2064933A1 Carrier protein
10/20/1992CA1309056C Forming heat-resistant layer by irradiation of polyether based photopolymer
10/20/1992CA1309046C Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols
10/20/1992CA1309039C Monoclonal antibody, process for preparing same, reagent for detecting cancer antigen containing the monoclonal antibody and process for preparing same
10/20/1992CA1309019C Combinations having synergistic growth hormone releasing activity and methods for use thereof
10/20/1992CA1309018C Prolonged release or biologically active polypeptides
10/19/1992WO1992018540A1 Anti-human immunodeficiency virus recombinant antibodies
10/19/1992WO1992018537A1 Interleukin 6 composition and production thereof
10/19/1992WO1992018141A1 Compositions and methods for inhibiting elastase
10/19/1992CA2108689A1 Compositions and methods for inhibiting elastase
10/19/1992CA2085744A1 Interleukin-6 compositions, and a production process thereof
10/19/1992CA2065794A1 Heterocyclic amides
10/18/1992CA2066111A1 Compounds, vectors and methods for expressing human, cytosolic phospholipase a2
1 ... 2958 2959 2960 2961 2962 2963 2964 2965 2966 2967 2968 2969 2970 2971 2972 2973 2974 2975 2976 2977 2978 ... 3163